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TRP channelTRPA1 is a non-selective Ca2+ permeable channel located in the plasma membrane that functions as a cellular
sensor detecting mechanical, chemical and thermal stimuli, being a component of neuronal, epithelial, blood
and smoothmuscle tissues. TRPA1 has been shown to inﬂuence a broad range of physiological processes that in-
volve Ca2+-dependent signaling pathways. Herewe report that TRPA1 is expressed inMEG01 but not in platelets
at the protein level. MEG01 cells maturation induced by PMA results in attenuation of TRPA1 protein expression
and enhances thapsigargin-evoked Ca2+ entry without altering the release of Ca2+ from intracellular stores. In-
hibition of TRPA1 by HC-030031 results in enhancement of both thrombin- and thapsigargin-stimulated Ca2+
entry. Co-immunoprecipitation experiments revealed that TRPA1 associates with STIM1, as well as Orai1,
TRPC1 and TRPC6. Downregulation of TRPA1 expression byMEG01maturation, as well as pharmacological inhi-
bition of TRPA1 by HC-030031, results in enhancement of the association between STIM1 and Orai1. Altogether,
these ﬁndings provide evidence for a new and interesting function of TRPA1 in cellular function associated to the
regulation of agonist-induced Ca2+ entry by the modulation of STIM1/Orai1 interaction.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Transient receptor potential (TRP) ankyrin 1 (TRPA1) is a non-
selective Ca2+ permeable channel that belongs to the TRP superfamily
[1]. Like other TRP channels, the architecture of TRPA1 includes six
transmembrane domains (TMD)with the presumed pore loop between
TMD5 and TMD6 [2]. TRPA1 is structurally differentiated by a large
number of ankyrin repeats, which vary among species (up to 18 repeats
in humans), located in the intracellular N-terminal region of the protein
[3]. Ankyrin repeats are proposed as a key integration site for multiple
physiological signals that activates the channel [4]. Furthermore, the
C-terminal region of the channel comprises basic residues that confer
both chemical and voltage sensitivity to TRPA1 channel [5].
Activation of TRPA1 by physical stimuli (i.e., cold temperature, ultra-
violet light) or endogenous (i.e., Ca2+, reactive oxygen species, nitric
oxide) and exogenous (i.e., allyl isothiocyanates) ligands results in a
massive inﬂux of Ca2+ into the stimulated cells [6] which actives a
wide range of physiological events in different cell types [7–12]. Ca2+
is considered the most important physiological activator of TRPA1 [6].
A recent model proposes that ankyrin repeat structure includes aUniversity of Extremadura, Av.
00; fax: +34 927257110.
ights reserved.Ca2+-binding EF-hand domain which changes the overall ﬂexibility of
the channel structure and modulates the open probability by acting as
a soft spring [13]. Another novel study proposes that the acidic cytoplas-
mic C-terminal tail is also involved in the potentiation and inactivation
of TRPA1 channel [6].
Store-operated Ca2+ entry (SOCE), the most important mechanism
for Ca2+ inﬂux in non-excitable mammalian cells, is controlled by the
ﬁlling state of the intracellular Ca2+ stores [14]. Different molecules
have been reported to be involved in SOCE. Stromal interaction mole-
cule 1 (STIM1) is a Ca2+-binding protein identiﬁed both in the plasma
membrane and in themembrane of intracellular Ca2+ stores, the endo-
plasmic reticulum (RE) and acidic stores [15–17]. Depletion of these in-
tracellular Ca2+ stores is detected by STIM1, which re-localizes at sites
of close proximity to the plasma membrane and the ER membrane
allowing its association with two types of Ca2+ inﬂux SOC channels:
the Orai family and TRP canonical (TRPC) family channels [18,19].
SOCE has been reported to be modulated by different cell parame-
ters such as temperature [20] and redox status [21] and by intracellular
mechanisms like STIM1 phosphorylation [22] and adaptor proteins like
Homer family proteins [23]. Recent studies have demonstrated that pro-
teins implicated in the regulation of the intracellular Ca2+ homeostais
like the two-pore Ca2+ channel 2 (TPC2) [24], the sarco/endoplasmic
reticulum Ca2+-ATPases (SERCA) pump family [25,26], and the TRPC3
[27,28] modulates SOCE in different type cells by the regulation of the
association of STIM1 with Orai1.
Fig. 1. TRPA1 expression in the humanmegakaryoblastic cell lineMEG01 cells, DAMI cells,
megakaryocytes andhumanplatelets.MEG01, DAMI,megakaryocytes and platelet protein
lysates were immunoblotted, as described inMaterials andmethods section, to detect the
presence of TRPA1 channel. Membranes were probed with anti-actin antibody for protein
loading control. The results are representative of 3 independent experiments.
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channels in the regulation of SOCE in the megakaryoblastic lineage. Our
results indicate that TRPA1 expression decreases during PMA-induced
MEG-01 maturation and it is correlated with an increase of SOCE medi-
ated by an enhanced interaction of STIM1 and Orai1, which suggests a
functional role for TRPA1 in the modulation of SOCE in these cells.Fig. 2. Enhanced Rap1b expression during maturation of MEG-01 megakaryocytic cell
lines induced by PMA treatment. MEG01 cells were cultured in the absence or presence
of 10 nMPMA for up0 to 4 days and treated ornotwith 60 μMHC-030031. Protein lysates
were immunoblotted for detect the presence of Rap1b. The bottompanels show represen-
tatives images ofWesternblotting experiments. Themean value of the cells treated for day
0 was arbitrarily taken as 100%. The results are representative of 6 independent experi-
ments. ⁎p b 0.05 compared with their control. #p b 0.05 compared with their control
(cells treated with HC-030031).2. Materials and methods
2.1. Materials
Fura-2 acetoxymethyl ester (fura-2/AM) and calcein were from
Invitrogen (Madrid, Spain). Thrombin, thapsigargin (TG), apyrase
(grade VII), dimethyl BAPTA/AM, aspirin, leupeptin, benzamidine, phenyl
methyl sulphonyl ﬂuoride (PMSF), sodium dodecyl sulfate (SDS), rabbit
anti-Orai1 antibody (C-terminal), 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-
tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide (HC-
030031), allyl isothiocyanate (AITC), nonidet P-40, phorbol 12-
myristate 13-acetate (PMA) and bovine serum albumin (BSA) were
from Sigma (Madrid, Spain). Mouse anti-STIM1 antibody was from BD
Transduction Laboratories (Franklin Lakes, NJ, U.S.A.). Rabbit anti-
hTRPC1 antibody, goat anti-hTRPC6 antibody and horseradish peroxi-
dase-conjugated donkey anti-goat IgG antibody were from Santa Cruz
Biotechnology (Santa Cruz, CA, U.S.A.). Horseradish peroxidase-conju-
gated goat anti-mouse IgG and goat anti-rabbit IgG antibodies were
from Jackson Immunoresearch (Suffolk, U.K.). Hyperﬁlm ECL was from
Amersham (Buckinghamshire, U.K.). Protein A-agarose was from Up-
state Biotechnology Inc. (Madrid, Spain). Enhanced chemiluminescence
detection reagents were from Pierce (Cheshire, U.K.). All other reagents
were of analytical grade.2.2. Platelet preparation
Platelets were prepared as previously described [29], as approved by
Local Ethical Committees and in accordance with the Declaration of
Helsinki. Brieﬂy, blood was obtained from healthy drug-free volun-
teers and mixed with one-sixth volume of acid/citrate dextrose anti-
coagulant containing (in mM): 85 sodium citrate, 78 citric acid and
111 D-glucose. Platelet-rich plasma (PRP) was then prepared by cen-
trifugation for 5 min at 700 ×g and aspirin (100 μM) and apyrase
(40 μg/mL) were added. Cells were then collected by centrifugation
at 350 ×g for 20 min and resuspended in HEPES-buffered saline
(HBS), pH 7.45, containing (in mM): 145 NaCl, 10 HEPES, 10 D-glucose,
5 KCl, 1 MgSO4 and supplemented with 0.1% (w/v) BSA and 40 μg/mL
apyrase. For BAPTA loading, cells were incubated with 10 μM dimethyl
BAPTA for 30 min and then resuspended in HBS.Fig. 3. Abolished TRPA1 expression during PMA-induced maturation of MEG-01 cells.
MEG01 cells were cultured in the absence or presence of 10 nM PMA and/or 60 μM HC-
030031 for 0 to 4 days. Protein lysates were inmunoblotted to detect TRPA1 expression.
The bottom panels show images representative of ﬁve others. The mean value of the
cells at day 0 was arbitrarily taken as 100%. *, p b 0.05 compared with control.
Fig. 4. Effect of HC-030031 on thrombin and thapsigargin-evoked Ca2+ entry inMEG01 cells andmegakaryocytes. Fura 2-loadedMEG01 cellswere incubated at 37 °C for 10 min in the pres-
ence of 60 μMHC-030031 or the vehicle (control) and then stimulatedwith 0.1 U/mL thrombin (A and C) or 1 μMthapsigargin (E andG) in a Ca2+ freemedium (200 μMEGTA) (A and E) or
in thepresenceof 1 mMextracellular Ca2+ (C andG). Traces shown are representative of 8 separate experiments. Histograms represent the amount of Ca2+mobilization induced by agonists
in the presence of HC-030031 as comparedwith their respective controls. Values aremeans ± S.E.M. *, p b 0.05 comparedwith control. I and J, fura 2-loadedmegakaryocyteswere incubated
at 37 °C for 10 min in the presence of 60 μMHC-030031 or the vehicle (control) and then stimulated with 0.1 U/mL thrombin (I) or 1 μM thapsigargin (J) in a Ca2+ free medium (200 μM
EGTA), subsequently, CaCl2 (1 mM) was added to the extracellular medium to initiate Ca2+ entry. Traces shown are representative of 3 separate experiments.
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The human megakaryoblastic cell lines MEG01 and DAMI were
obtained from ATCC (Manassas, VA, USA) and cultured at 37 °C with a
5% CO2 in RPMI media, supplemented with 10% heat-inactivated fetal
calf serum, 2 mM L-glutamine and 50 μg/mL gentamycin.
At the time of the experiments cells were suspended in basic salt so-
lution (BSS) containing (inmM): 125 NaCl, 5 KCl, 1 MgCl2, 5 glucose, 25
HEPES, and pH 7.3. This is supplemented with 0.1% (w/v) BSA and apy-
rase (0.02 U/mL).
Megakaryocytic cell-line maturation was induced using PMA, a pro-
tein kinase C activator [30]. For this purpose, MEG01 cells were cultured
in RPMI media containing 10−8 M PMA for up to 4 days of culture.
2.4. Isolation of human megakaryocytes
Human megakaryocytes were isolated as described previously [31].
Brieﬂy, umbilical cord blood was collected under informed consent dur-
ing normal full-term deliveries and used within 48 h. CD34+ stem cells
were isolated using theminiMACS CD34 progenitor cell isolation system
fromMiltenyi Biotec (Bergisch Gladbach, Germany). Cells were cultured
for either 7 or 14 days. Day 7 cells were labeledwith anti-CD61 antibody
(7F12) and day 14 cells were labeled with anti-CD42b antibody, for
20 min at 4 °C. Cells were then labeled for 20 min (4 °C) with goat-
anti-mouse magnetic microbeads. The cell suspension was brought on
a ferromagnetic column, type MS+ (Miltenyi Biotec), and after three
washing steps with 700 μl buffer A (PBS containing 0.5% BSA and
2.5 mM EDTA) each, the retained cells were eluted with buffer A.
2.5. Immunoprecipitation and Western blotting
The immunoprecipitation and Western blotting were performed as
described previously [32]. Brieﬂy, 500 μL aliquots of MEG01 suspensionFig. 5. Effect of allyl isothiocyanate (AITC) on thapsigargin and thrombin-evoked Ca2+ entry inM
5 μMAITC or thevehicle (control) and then stimulatedwith 0.1 U/mL thrombin (A)or 1 μMthap
separate experiments. B and D, Histograms indicating the amount of Ca2+ mobilization induced(1 × 107 cell/mL) were lysed with an equal volume of NP-40 buffer,
pH 8, containing 274 mM NaCl, 40 mM Tris, 4 mM EGTA, 20% glycerol,
2% nonidet P-40, 2 mMNa3VO4, 2 mM PMSF, 100 μg/mL leupeptin and
10 mM benzamidine.
Aliquots of MEG01 lysates (1 mL) were immunoprecipitated by in-
cubation with 2 μg of either anti-STIM1, anti-Orai1, anti-hTRPC1 or
anti-hTRPC6 and 25 μL of protein A-agarose overnight at 4 °C on a
rocking platform. The immunoprecipitates were resolved by 8% SDS–
PAGE and separated proteins were electrophoretically transferred
onto nitrocellulose membranes for subsequent probing. Blots were in-
cubated for 1 h at room temperature with 10% (w/v) BSA in tris-buff-
ered saline with 0.1% Tween 20 (TBST) to block residual protein
binding sites. Immunodetection of STIM1, Orai1, hTRPC1 and hTRPC6
was achieved using the anti-STIM1 antibody or the anti-Orai1 antibody
diluted 1:250 in TBST for 2 h and the anti-hTRPC1 or anti-hTRPC6 dilut-
ed 1:200 in TBST for 2 h respectively at room temperature. The primary
antibody was removed and blots were washed six times for 5 min each
with TBST. To detect the primary antibody, blots were incubated for
45 min with the appropriate horseradish peroxidase-conjugated
secondary antibody diluted 1:10000 in TBST and then exposed to en-
hanced chemiluminiscence reagents for 4 min. Blotswere then exposed
to photographic ﬁlms. The density of bands on the ﬁlm was measured
using scanning densitometry and analyzed using ImageJ software for
gel analysis fromNIH.Datawere normalized to the amount of actin pro-
tein or the amount of protein recovered by the antibody used for the
immunoprecipitation.
For each antibody-based immunoprecipitationwe performed an an-
tibody-free, protein A-agarose only control in order to ensure that the
proteins immunoprecipitated are not pulled down by protein A-agarose
itself. In addition, for each antibody used in Western blotting a primary
antibody-free control was carried out to conﬁrm that the detection is
speciﬁc and not due to non-speciﬁc binding by the secondary antibody
(data not shown).EG01 cells. Fura 2-loadedMEG01 cellswere incubated at 37 °C for 10 min in thepresence of
sigargin (C) in thepresence of 1 mMextracellular Ca2+. Traces shownare representative of 8
by 0.1 U/mL thrombin (B) and 1 μM thapsigargin (D). Values are means ± S.E.M.
Fig. 6. Effect of PMA-induced maturation on thapsigargin-evoked Ca2+ entry in MEG01
cells. MEG01 cells were cultured in the absence (control) or presence of 10 nM PMA dur-
ing 2 and 4 days. Afterwards, fura 2-loaded MEG01 cells were stimulated with 1 μM
thapsigargin in a Ca2+ free medium, and 3 min later 600 μM Ca2+ was added to initiate
Ca2+ entry. (A) The traces shown are representative of 5 separate experiments. B, Histo-
grams indicating the amount of thapsigargin-induced Ca2+ entry after 2 and 4 days of
treatment with PMA as compared to control. Values are means ± S.E.M. *, p b 0.05 com-
pared with control.
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Cells were loadedwith fura-2 by incubationwith 2 μM fura 2/AM for
45 min at 37 °C. Coverslips with cultured cells were mounted on a per-
fusion chamber and placed on the stage of an epiﬂuorescence inverted
microscope (Nikon Diaphot T200, Melville, NY, USA) with image acqui-
sition and analysis system for videomicroscopy (Hamamatsu Photonics,
Hamamatsu, Japan). Cells were continuously superfused with BSS. Cells
were alternatively excitedwith light from a xenon lamp passed through
a high-speed monochromator (Polychrome IV, Photonics, Hamamatsu,
Japan) at 340/380 nm. Fluorescence emission at 505 nm was detected
using a cooled digital CCD camera (Hisca CCD C-6790, Hamamatsu,
Japan) and recorded using Aquacosmos 2.5 software (Hamamatsu Pho-
tonics, Hamamatsu, Japan). Ca2+ entrywas estimated using the integral
of the rise in fura-2 ﬂuorescence 340/380 nm ratio for 2 min after addi-
tion of CaCl2. Ca2+ releasewas estimated using the integral of the rise in
fura-2 ﬂuorescence 340/380 nm ratio for 2 min after the addition of
thrombin or TG, in presence or absence of 60 μM HC-030031 or 5 μM
AITC.
To calculate the initial rate of Ca2+ elevation after the addition of
Ca2+ to the medium, the traces were ﬁtted to the equation y =
A + Kx where K is the slope.
2.7. Statistical analysis
Analysis of statistical signiﬁcance was performed using Student's t-
test for comparison between two groups. p b 0.05 was considered to
be signiﬁcant for a difference.3. Results
3.1. TRPA1 is expressed in human MEG01 and DAMI cells and megakaryo-
cytes but not in platelets
Even though TRPA1 mRNA expression has been reported in human
platelets [33], we have further explored the expression of TRPA1 at
the protein level in human platelets by using Western blotting. As
shown in Fig. 1, Western blotting of whole cell platelet lysates using a
speciﬁc anti-TRPA1 antibody failed to detect TRPA1 in human platelets.
By contrast, under the same experimental conditions, the anti-TRPA1
antibody was able to detect a single band, at 140 kDa (the predicted
TRPA1 size), in the human megakaryoblastic cell lines MEG01 and
DAMI and human megakaryocytes (Fig. 1A).
3.2. Effect of MEG01 maturation in TRPA1 expression
Since we have observed that TRPA1 protein is not expressed in
human platelets but it was found in the megakaryoblastic cell line
MEG01we explored whether the expression of this channel is modiﬁed
during the process of maturation. Maturation was induced using PMA,
an activator of protein kinase C [30]. Rap1b protein, a ubiquitous Ras-re-
lated GTPase that increased with megakaryocytic maturation, was used
as a maturation marker [34–37]. Treatment of MEG01 cells with 10 nM
PMA resulted in a signiﬁcant and time-dependent increase in Rap1b ex-
pression as compared to control cells treated with vehicle, where the
expression of Rap1b was not modiﬁed during the 4 days of the experi-
ment (Fig. 2, top panel and graph; p b 0.05; n = 6). In order to investi-
gate the possible role of TRPA1 in maturation, cells were treated with
the TRPA1 speciﬁc inhibitor HC-030031 [38–40]. MEG01 cells were
treated with 60 μM HC-030031 and the expression of Rap1b was ana-
lyzed every 24 h during 4 days. As shown in Fig. 2, treatment with
HC-030031 neither modiﬁed the expression of Rap1b per se nor altered
PMA-induced Rap1b expression increase; thus demonstrating that
TRPA1 activity has a negligible effect, if any, in MEG01 cell maturation.
Reprobing of the same membranes with anti-actin antibody was
performed for protein loading control and revealed a similar amount
of protein loaded in all lanes (Fig. 2, bottom panels).
As reported in Fig. 3, treatment of MEG01 cells with 10 nM PMA sig-
niﬁcantly reduced TRPA1 expression in a time-dependentmanner, with a
detectable attenuation of TRPA1 protein expression after 24 h of treat-
ment with PMA (p b 0.05; n = 6). Reprobing of the same samples with
anti-actin antibody revealed a comparable amount of protein loaded in
all lanes (Fig. 3, bottom panel). By contrast, MEG01 cells treatment with
the TRPA1 inhibitor did not alter TRPA1protein expression at least during
theﬁrst 4 days of treatment as compared to control (vehicle added); thus
conﬁrming that this inhibitor does not modify the expression of TRPA1.
These ﬁndings indicate that, while TRPA1 function is not relevant for
MEG01maturation induced by PMA,maturation itself signiﬁcantly atten-
uates TRPA1 protein expression, thus explaining the expression of TRPA1
in megakaryoblastic cells but not in mature human platelets.
3.3. Role of TRPA1 in Ca2+ mobilization
Since TRPA1 is expressed inMEG01 cells we have investigated its in-
volvement in Ca2+ mobilization induced by physiological agonists. As
shown in Fig. 4A and B, treatment of MEG01 cells with thrombin in a
Ca2+-free medium resulted in a transient increase in [Ca2+]i due to
Ca2+ release from intracellular Ca2+ stores [41]. Pretreatment of the
cells for 10 min with 60 μM HC-030031, a TRPA1 inhibitor [38], did
not signiﬁcantly alter either resting [Ca2+]i or thrombin-induced Ca2+
release (the integral of the rise in fura-2 ﬂuorescence 340/380 nm
ratio for 2 min after the addition of thrombin in the absence or presence
of HC-030031were 3087 ± 504 and 2994 ± 412, respectively; n = 8).
In the presence of 1 mMextracellular Ca2+, thrombin induced a greater
elevation in [Ca2+]i than that obtained in a Ca2+-free medium as a
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with HC-030031 signiﬁcantly enhanced thrombin-evoked Ca2+mobili-
zation in the presence of 1 mMextracellular Ca2+, thus, suggesting that
inhibition of TRPA1 function enhances Ca2+ entry evoked by thrombin
(Fig. 4C and D, p b 0.05; n = 8).
Thrombin has been reported to induce both capacitative (store-op-
erated) and non-capacitative Ca2+ entry [42]. Hence, we have investi-
gated the role of TRPA1 in store-operated Ca2+ entry (SOCE) in
MEG01 cells. In a Ca2+-free medium, TG, a speciﬁc inhibitor of the
sarco/endoplasmic-reticulum Ca2+-ATPase [43], evoked a sustained el-
evation of [Ca2+]i in MEG01 cells owing to the release of Ca2+ from in-
tracellular pools, which was insensitive to treatment of MEG01 cellsFig. 7. Thrombin stimulates the association of TRPA1 with STIM1 and the Ca2+-permeable ch
Ca2+-free BSS. Cells were stimulated with 0.1 U/mL thrombin for 3 min or left untreated (c
anti-TRPC1 antibody (B), anti-TRPC6 antibody (C) or anti-Orai1 antibody (D), followed by
immunoprecipitating antibody for protein loading control. Histograms represent the interact
shown are representative of 4–5 independent experiments. Values are means ± S.E.M.. *, p bwith the TRPA1 inhibitor HC-030031 (the integral of the rise in fura-2
ﬂuorescence 340/380 nm ratio for 2 min after the addition of TG in
the absence or presence of HC-030031 was 1207 ± 201 and 1170 ±
112, respectively; Fig. 4E and F). In the presence of 1 mM extracellular
Ca2+ TG-evoked a prolonged and greater increase in [Ca2+]i due to
both Ca2+ release from internal stores and the subsequent activation
of SOCE. As for thrombin, treatment with HC-030031 signiﬁcantly en-
hanced TG-evoked Ca2+ mobilization in the presence of extracellular
Ca2+, which is entirely dependent on the effect of TRPA1 on the activa-
tion of SOCE (Fig. 4G and H, p b 0.05; n = 8). Similar results were ob-
served in human megakaryocytes. As shown in Fig. 4I and J, treatment
of megakaryocytes with thrombin or TG in a Ca2+-free mediumannels Orai1, TRPC1 and TRPC6. Dimethyl BAPTA-loaded MEG01 cells were suspended in
ontrol) and lysed. Cell lysates were immunoprecipitated with anti-STIM1 antibody (A),
Western blotting using an anti-TRPA1 antibody. Membranes were reprobed with the
ion of TRPA1 with the different proteins in resting and thrombin-stimulated cells. Data
0.05 compared with control.
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lar stores. Subsequent addition of Ca2+ resulted in a further elevation in
[Ca2+]i indicative of Ca2+ entry. Treatment for 10 min with 60 μMHC-
030031 signiﬁcantly enhanced thrombin and TG-induced Ca2+ entry by
22 and 27%, respectively, without having any effect on Ca2+ release
from the intracellular stores. These ﬁndings demonstrate that TRPA1
is a regulator of SOCE in MEG01 cells and megakaryocytes.
We have further explored whether TRPA1 activation results in any
change in agonist-induced Ca2+ mobilization. As depicted in Fig. 5,
treatment of MEG01 cells with 5 μM AITC did not modify [Ca2+]i.Fig. 8. Thapsigargin evokes the association of TRPA1 with STIM1 and the Ca2+-permeable cha
Ca2+-free BSS. Cells were stimulated with 1 μM thapsigargin for 3 min or left untreated (cont
TRPC1 antibody (BA), anti-TRPC6 antibody (C) or anti-Orai1 antibody (DE), followed by
immunoprecipitating antibody for protein loading control. Histograms represent the interactio
shown are representative of 4 independent experiments. Values are means ± S.E.M.. *, p b 0.0Pharmacological activation of TRPA1 using AITC did not alter either
thrombin- or TG-evoked Ca2+ mobilization (n = 8).
We have further investigated the role of TRPA1 in SOCE in MEG01
cells byusing an approachbased on thedownregulationof TRPA1 expres-
sion during MEG01 maturation. As depicted in Fig. 3, the expression of
TRPA1 is time-dependently attenuated during maturation; therefore,
we have tested TG-evoked Ca2+ entry in control MEG01 cells and cells
treated with PMA for 2 and 4 days. As shown in Fig. 6, top panel, treat-
mentwith PMAdid not alter TG-evoked Ca2+ release from the intracellu-
lar stores but signiﬁcantly enhanced TG-evoked SOCE (p b 0.05; n = 5).nnels Orai1, TRPC1 and TRPC6. Dimethyl BAPTA-loaded MEG01 cells were suspended in
rol) and lysed. Cell lysates were immunoprecipitated with anti-STIM1 antibody (A), anti-
Western blotting using an anti-TRPA1 antibody. Membranes were reprobed with the
n of TRPA1 with the different proteins in resting and thapsigargin-stimulated cells. Data
5 compared with control.
3032 L. Albarrán et al. / Biochimica et Biophysica Acta 1833 (2013) 3025–3034Although we cannot rule out other possible mechanisms involved in the
enhancement of Ca2+ entry, these ﬁndings indicate that maturation re-
sults in an increase in SOCE in these cells, probably due to the attenuation
of TRPA1 protein expression, consistent with the results found using the
TRPA1 inhibitor HC-030031 (Fig. 4).
As expected, treatment of human platelets with AITC or HC-030031
did not result in any change in [Ca2+]i or alter agonist-evoked Ca2+mo-
bilization (data not shown), which is consistent with the lack of TRPA1
protein expression in these cells (Fig. 1).3.4. TRPA1 associates with SOCE elements in MEG01 cells
In human platelets, we have reported that SOCE requires the associa-
tion of STIM1 and the Ca2+ permeable channels Orai1, TRPC1 and TRPC6
[15,44–46]. Hence we have investigated the association of TRPA1 with
these proteins by looking for co-immunoprecipitation from MEG01 ly-
sates. Cells loaded with dimethyl BAPTAwere used in order to eliminate
Ca2+-dependent responses. Immunoprecipitation and subsequent SDS–
PAGE andWestern blotting were conducted using control cells and cells
stimulated with the physiological agonist thrombin. After immunopre-
cipitation of whole cell lysates with the anti-STIM1 antibody, Western
blotting revealed the presence of TRPA1 in samples from cells stimulated
by thrombin and control. Interestingly, treatment with thrombin signiﬁ-
cantly enhanced the association of TRPA1with STIM1 (Fig. 7A, top panel;
p b 0.05; n = 5). Similar results were observed when cells were stimu-
lated with TG (Fig. 8; p b 0.05; n = 4). Western blotting with anti-
STIM1 antibody revealed a similar content of this protein in all lanes
(Figs. 7A and 8A, bottom panel).
Furthermore, we found association of TRPA1with TRPC1, TRPC6 and
Orai1 both in resting and thrombin-stimulated MEG01 cells (Fig. 7B–D,
top panel). Thrombin-evoked a signiﬁcant increase in the association of
TRPA1 with these channels as compared to controls (p b 0.05; n = 5),
and similar results were found when cells were stimulated with TGFig. 9. TRPA1 negatively regulates the association of STIM1 with Orai1 in MEG01 cells. A, MEG
4 days. Dimethyl BAPTA-loaded cells were stimulated with 0.1 U/mL thrombin for 3 min or le
followed byWestern blotting using an anti-Orai1 antibody. B, Dimethyl BAPTA-loaded MEG01
with 0.1 U/mL thrombin for 3 min of left untreated and lysed. Cell lysateswere immunoprecipit
Histograms represent the interaction of STIM1 with Orai1. Data shown are representative of 4(Fig. 8; p b 0.05; n = 5), thus, suggesting that TRPA1 takes part in the
macromolecular complex regulating SOCE in these cells.
3.5. TRPA1 regulates the association between STIM1 and Orai1 in MEG01
cells
Finally, we have investigated the mechanism underlying the regula-
tion of SOCE by TRPA1 in MEG01 cells. The association between STIM1
and Orai1 has been reported to be crucial for the activation of SOCE
[46–48]. Hence we have investigated whether TRPA1 might regulate
the association between these proteins in dimethyl BAPTA-loaded
cells. We have tested this possibility by using two different approaches.
First of all, we tested the effect of maturation in the association between
STIM1 and Orai1 induced by agonist, taking into account that matura-
tion downregulates TRPA1 expression. Alternatively, we tested the ef-
fect of the TRPA1 inhibitor, HC-030031, in the association between
STIM1 and Orai1 induced by agonists. Concerning the ﬁrst approach,
we have tested the association between STIM1 and Orai1 in control
MEG01 cells and cells treated with PMA for 2 and 4 days. As shown in
Fig. 9A, top panel, treatment with PMA for 2 or 4 days signiﬁcantly en-
hanced the association between STIM1 and Orai1 in these cells induced
by thrombin (p b 0.05; n = 4). Consistent with a role for TRPA1 in the
STIM1/Orai1 association we found that HC-030031 signiﬁcantly in-
creased thrombin-induced association between STIM1 and Orai1, with-
out having any effect on the association between these proteins in
resting cells (p b 0.05; n = 4) (Fig. 9B, top panel). These ﬁndings
strongly indicate that TRPA1modulates SOCE inMEG01 cells by attenu-
ation of the association between STIM1 and Orai1.
4. Discussion
TRP channels have been reported to play a relevant role in cell func-
tion,mostly due to the conductionof cation currents throughmembranes.01 cells were cultured in the absence (control) or presence of 10 nM PMA during 2 and
ft untreated and lysed. Cell lysates were immunoprecipitated with anti-STIM1 antibody,
cells were treated with 60 μMHC-030031 or the vehicle (as control) and then stimulated
atedwith anti-STIM1 antibody, followed byWestern blotting using an anti-Orai1 antibody.
independent experiments. Values are means ± S.E.M. *, p b 0.05 compared with control.
3033L. Albarrán et al. / Biochimica et Biophysica Acta 1833 (2013) 3025–3034Especially relevant is the role of TRP channels in Ca2+ inﬂux from the ex-
tracellular medium [49]. In addition, a new role for TRP channels in the
regulation of Ca2+movements through other channels is emerging. To il-
lustrate this statement, TRPC1 has been recently reported as a negative
regulator of TRPV6-mediated Ca2+ inﬂux through the attenuation of
TRPV6 expression in the plasma membrane [50]. In the present study
we report for the ﬁrst time the role of TRPA1 as a negative regulator of
SOCE in MEG01 cells and megakaryocytes. This ﬁnding has been demon-
strated using two different approaches: channel silencing expression as a
result of PMA-induced maturation of MEG01 cells, as well as inactivation
of TRPA1 function using a pharmacological tool. Althoughwe cannot rule
out that MEG01 cell maturation results in enhancement of SOCE also by
mechanisms different from TRPA1 expression downregulation, inactiva-
tion of TRPA1 by using HC-030031 produced basically the same effects,
which strongly suggests that SOCE enhancement during maturation is,
at least partially, dependent on TRPA1. Treatment of MEG01 cells with
HC-030031 did not signiﬁcantly alter Ca2+ release stimulated by throm-
bin or passive Ca2+ efﬂux induced by TG, which indicates that this inhib-
itor does not alter the ability of cells to accumulate Ca2+ into the
intracellular stores or the ability of thrombin to induce Ca2+ release
from the stores. Furthermore, these ﬁndings suggest that TRPA1 is not in-
volved in agonist-induced Ca2+ release or Ca2+ leakage from the intracel-
lular Ca2+ compartments.
TRPA1 negatively regulates Ca2+-independent association of STIM1
with Orai1, which might be the mechanism underlying the modulation
of SOCE inMEG01 cells. The regulation of signaling complexes by TRPA1
resembles that previously reported to TRPC3, which recruits Orai1,
STIM1, RACK1 and the type I IP3 receptor into a TRPC3-dependent
signalplex that modulates agonist-induced Ca2+ release and entry in
HEK-293 cells [27,28]. We have found that TRPA1 is constitutively asso-
ciated to STIM1 and Orai1, although these interactions are enhanced by
stimulation with agonists. Furthermore, our results indicate that TRPA1
is constitutively active, since cell treatment with AITC, a TRPA1 activa-
tor, did not result in further inhibition of agonist-induced Ca2+ entry
and SOCE.
Interestingly, the role of TRPA1 as a SOCEmodulator disappearswith
maturation so thatmature human platelets do not express TRPA1 at the
protein level, thus resulting in a signiﬁcantly greater SOCE in platelets
upon depletion of the intracellular Ca2+ stores by TG, as demonstrated
in Fig. 10, which depicts the determination of SOCE inMEG01 and plate-
lets performed under comparable conditions. The present study pre-
sents a new and interesting function of TRPA1 channels in cellular
function not associated with the previously reported thermal and nox-
ious sensitivity [51]. This new feature described here should be taken
into account in the design of therapeutic drugs aimed at the modiﬁca-
tion of calcium entry.Fig. 10. Comparative analysis of TG-evoked store-operated Ca2+ entry inMEG01 cells and
platelets. MEG01 cells and human platelets were suspended in BSS and HBS, respectively.
Fura 2-loaded cells were stimulated with 1 μM TG in a Ca2+-free medium (200 μM EGTA
added) and 3 min later CaCl2 (ﬁnal concentration 600 μM) was added to initiate Ca2+
entry. Traces shown are representative of 5 separate experiments.Acknowledgements
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